| Literature DB >> 22143549 |
Elsa Moreno1, Elisabetta Gabano, Enrique Torres, James A Platts, Mauro Ravera, Ignacio Aldana, Antonio Monge, Silvia Pérez-Silanes.
Abstract
As reported in our previous papers, a series of quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives were synthesized and studied as anti-tuberculosis agents. Here, the capability of the shake-flask method was studied and the retention time (expressed as log K) of 20 compounds were determined by RP-HPLC analysis. We found that the prediction of log P by the RP-HPLC analysis can result in a high accuracy and can replace the shake-flask method avoiding the experimental problems presented by quinoxaline di-N-oxides. The studied compounds were subjected to the ALOGPS module with the aim of comparing experimental log P(o/w) values and predicted data. Moreover, a preliminary in silico screening of the QSAR relationship was made confirming the influence of reduction peak potential, lipophilicity, H-bond donor capacity and molecular dimension descriptors on anti-tuberculosis activity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22143549 PMCID: PMC6264295 DOI: 10.3390/molecules16097893
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
log P, log k’ and related RP-HPLC log P values for the reference compounds.
| Name | Code | log
| log
| RP-HPLC log
| LOO-predicted RP-HPLC log
|
|---|---|---|---|---|---|
| 2-Butanone | 0.3 | −0.06 | 0.21 | 0.15 | |
| Aniline | 0.9 | 0.67 | 0.94 | 0.96 | |
| Acetanilide | 1.0 | 0.88 | 1.15 | 1.19 | |
| Acetophenone | 1.7 | 1.27 | 1.54 | 1.52 | |
| Benzene | 2.1 | 1.87 | 2.14 | 2.14 | |
| Chlorobenzene | 2.8 | 2.62 | 2.89 | 2.90 | |
| Bromobenzene | 3.0 | 2.84 | 3.10 | 3.12 | |
| Naphthalene | 3.6 | 3.15 | 3.42 | 3.36 | |
| Benzyl benzoate | 4.0 | 3.74 | 4.01 | 4.01 |
a Reference log P values taken from OECD Guidelines.
Capacity factors and related RP-HPLC log P for QdO.
| Capacity factors | RP-HPLC log
| |||||||
|---|---|---|---|---|---|---|---|---|
| R | R7/R6 | Comp. | log
| log
| log
| log
| log
| |
| C6H5-CH2 | H/H | −0.64 | −0.34 | −0.05 | 0.28 | 1.49 | 1.76 | |
| CH3/H | −0.56 | −0.24 | 0.07 | 0.35 | 1.58 | 1.85 | ||
| Cl/H | −0.36 | −0.05 | 0.30 | 0.65 | 1.98 | 2.25 | ||
| Cl/Cl | −0.11 | 0.27 | 0.66 | 0.98 | 2.46 | 2.72 | ||
| 2-phenylethyl | H/H | −0.58 | −0.26 | 0.05 | 0.36 | 1.61 | 1.88 | |
| CH3/H | −0.45 | −0.13 | 0.21 | 0.47 | 1.73 | 2.00 | ||
| Cl/H | −0.37 | 0.00 | 0.36 | 0.69 | 2.11 | 2.38 | ||
| Cl/Cl | −0.06 | 0.34 | 0.74 | 1.07 | 2.60 | 2.87 | ||
| H/H | −0.24 | 0.11 | 0.48 | 0.85 | 2.30 | 2.57 | ||
| CH3/H | −0.16 | 0.21 | 0.60 | 0.94 | 2.43 | 2.69 | ||
| Cl/H | 0.02 | 0.42 | 0.84 | 1.22 | 2.83 | 3.09 | ||
| Cl/Cl | 0.19 | 0.65 | 1.15 | 1.60 | 3.51 | 3.78 | ||
| H/H | −0.44 | −0.10 | 0.25 | 0.62 | 2.02 | 2.29 | ||
| CH3/H | −0.36 | −0.01 | 0.34 | 0.66 | 2.02 | 2.29 | ||
| Cl/H | −0.25 | 0.15 | 0.54 | 0.93 | 2.51 | 2.77 | ||
| Cl/Cl | 0.14 | 0.54 | 0.93 | 1.33 | 2.91 | 3.18 | ||
| 2,2-diphenylethyl | H/H | −0.33 | 0.14 | 0.62 | 1.06 | 2.92 | 3.18 | |
| CH3/H | −0.12 | 0.33 | 0.80 | 1.21 | 3.02 | 3.28 | ||
| Cl/H | −0.13 | 0.38 | 0.91 | 1.38 | 3.42 | 3.69 | ||
| Cl/Cl | 0.25 | 0.76 | 1.31 | 1.78 | 3.86 | 4.12 | ||
Calculated log P for quinoxaline derivatives and related RMSE.
| Comp. | RP-HPLC log | Calculated log
| ||||||
|---|---|---|---|---|---|---|---|---|
| ALOGPs | miLOGP | ALOGP | MLOGP | LogKOW | XLOGP2 | XLOGP3 | ||
| 1.76 | 0.43 | −0.48 | 1.11 | −1.71 | 0.55 | 5.03 | 1.28 | |
| 1.85 | 0.50 | −0.05 | 1.60 | −1.47 | 1.10 | 5.46 | 1.64 | |
| 2.25 | 1.03 | 0.18 | 1.77 | −1.20 | 1.20 | 5.65 | 1.90 | |
| 2.72 | 1.72 | 0.78 | 2.44 | −0.70 | 1.84 | 6.27 | 2.53 | |
| 1.88 | 0.63 | −0.07 | 1.43 | −1.47 | 1.04 | 5.18 | 1.74 | |
| 2.00 | 0.80 | 0.35 | 1.92 | −1.24 | 1.59 | 5.62 | 2.10 | |
| 2.38 | 1.25 | 0.58 | 2.09 | −0.97 | 1.69 | 5.80 | 2.37 | |
| 2.87 | 2.03 | 1.19 | 2.76 | −0.47 | 2.33 | 6.43 | 2.99 | |
| 2.57 | 1.14 | 0.33 | 1.86 | −1.08 | 1.44 | 5.82 | 1.97 | |
| 2.69 | 1.29 | 0.76 | 2.34 | −0.85 | 1.99 | 6.26 | 2.33 | |
| 3.09 | 1.82 | 0.99 | 2.52 | −0.59 | 2.09 | 6.44 | 2.60 | |
| 3.78 | 2.74 | 1.59 | 3.19 | −0.09 | 2.73 | 7.07 | 3.22 | |
| 2.29 | 0.56 | −0.03 | 1.60 | −1.47 | 1.10 | 5.46 | 1.64 | |
| 2.29 | 0.75 | 0.40 | 2.08 | −1.24 | 1.65 | 5.90 | 2.01 | |
| 2.77 | 1.22 | 0.63 | 2.26 | −0.97 | 1.74 | 6.08 | 2.27 | |
| 3.18 | 2.31 | 1.07 | 2.71 | −0.36 | 2.16 | 6.71 | 2.90 | |
| 3.18 | 1.78 | 1.31 | 2.78 | −0.35 | 2.16 | 6.67 | 3.19 | |
| 3.28 | 1.98 | 1.74 | 3.27 | −0.14 | 2.71 | 7.11 | 3.56 | |
| 3.69 | 2.36 | 1.97 | 3.45 | 0.12 | 2.81 | 7.29 | 3.82 | |
| 4.12 | 3.19 | 2.57 | 4.11 | 0.60 | 3.45 | 7.92 | 4.45 | |
| 1.28 | 1.96 | 0.43 | 3.52 | 0.89 | 3.47 | 0.36 | ||
Calculated log P for quinoxaline derivatives using ALOGPS with and without LIBRARY mode.
| Comp. | RP-HPLC log
| ALOGPs | ALOGPs LIBRARY |
|---|---|---|---|
| 1.88 | 0.63 | 1.93 | |
| 2.38 | 1.25 | 2.43 | |
| 2.00 | 0.80 | 2.08 | |
| 2.87 | 2.03 | 3.04 | |
| 2.57 | 1.14 | 2.40 | |
| 3.09 | 1.82 | 2.92 | |
| 2.69 | 1.29 | 2.54 | |
| 3.78 | 2.74 | 3.54 | |
| 2.29 | 0.56 | 1.90 | |
| 2.77 | 1.22 | 2.41 | |
| 2.29 | 0.75 | 2.06 | |
| 3.18 | 2.31 | 3.19 | |
| 3.18 | 1.78 | 3.18 | |
| 3.69 | 2.36 | 3.67 | |
| 3.28 | 1.98 | 3.33 | |
| 4.12 | 3.19 | 4.32 | |
| 1.29 | 0.19 |
Scheme 1General synthetic scheme.